DrugPatentWatch Database Preview

EXTRANEAL Drug Profile

Which patents cover Extraneal, and what generic alternatives are available?

Extraneal is a drug marketed by Baxter Hlthcare and is included in one NDA. There is one patent protecting this drug.

This drug has fourteen patent family members in nine countries.

The generic ingredient in EXTRANEAL is icodextrin. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the icodextrin profile page.

Summary for EXTRANEAL

International Patents:	14
US Patents:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	14
Clinical Trials:	6
Patent Applications:	1,179
Formulation / Manufacturing:	see details
DailyMed Link:	EXTRANEAL at DailyMed

Drug patent expirations by year for EXTRANEAL

Pharmacology for EXTRANEAL

Ingredient-type	Calcium Cations, Divalent
Drug Class	Osmotic Laxative Blood Coagulation Factor Calculi Dissolution Agent
Mechanism of Action	Osmotic Activity Magnesium Ion Exchange Activity
Physiological Effect	Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption Increased Coagulation Factor Activity Inhibition Small Intestine Fluid/Electrolyte Absorption Stimulation Large Intestine Fluid/Electrolyte Secretion

US Patents and Regulatory Information for EXTRANEAL

+ Get email alerts for changes to this table

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare	EXTRANEAL	icodextrin	SOLUTION;INTRAPERITONEAL	021321-001	Dec 20, 2002		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

or, see our see our flat-rate plans

Expired US Patents for EXTRANEAL

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Baxter Hlthcare	EXTRANEAL	icodextrin	SOLUTION;INTRAPERITONEAL	021321-001	Dec 20, 2002	➤ Sign Up	➤ Sign Up
Baxter Hlthcare	EXTRANEAL	icodextrin	SOLUTION;INTRAPERITONEAL	021321-001	Dec 20, 2002	➤ Sign Up	➤ Sign Up
Baxter Hlthcare	EXTRANEAL	icodextrin	SOLUTION;INTRAPERITONEAL	021321-001	Dec 20, 2002	➤ Sign Up	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

or, see our see our flat-rate plans

International Patents for EXTRANEAL

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration
United Kingdom	8610841	➤ Sign Up
Japan	S6248701	➤ Sign Up
Norway	168945	➤ Sign Up
United Kingdom	8515842	➤ Sign Up
Country	Document Number	Estimated Expiration

Summary for EXTRANEAL

Pharmacology for EXTRANEAL

For more information try a trial or see the plans and pricing